StockGlow

Precipio, Inc. (PRPO)

Runs blood cancer diagnostic tests using genetic panels and cell culture technology

$22.99+0.00%Healthcare
Compare PRPO with
StockGlow Score
27
Leaning Bearish
BearishBullish
1 year ago+59.0%

The outlook

PRPO is trading near the middle of its 52-week range at $22.99, but sits below both its 50- and 200-day moving averages, signaling downward momentum. Analyst coverage appears limited, and the overall sentiment leans bearish based on current market positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range46% of the way from its 52-week low to high
Market cap
$41.1M
52-wk high
$33.63
52-wk low
$13.80
50-day avg
$23.84
200-day avg
$24.29
Trailing P/E
—

Similar stocks

RHEPRegional Health Properties, Inc.$1.02+0.99%CFORCapForce Inc.$9.51-47.17%XBIOXenetic Biosciences, Inc.$2.49-0.40%VTVTvTv Therapeutics Inc.$31.18+0.52%COCPCocrystal Pharma, Inc.$0.94+2.05%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy